Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
47 hedge funds and large institutions have $33.6M invested in Alimera Sciences in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.
7% more capital inflows, than outflows
Capital inflows: $5.01M | Capital outflows: $4.68M
10.23% less ownership
Funds ownership: 58.13% → 47.91% (-10%)
13% less funds holding
Funds holding: 54 → 47 (-7)
21% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 14
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Stonepine Capital Management
Bend,
Oregon
|
+$3.31M |
| 2 |
Armistice Capital
New York
|
+$888K |
| 3 |
Avoro Capital Advisors
New York
|
+$561K |
| 4 |
Renaissance Technologies
New York
|
+$72.7K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$61K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
North Run Capital
Boston,
Massachusetts
|
-$2.16M |
| 2 |
J. Goldman & Co
New York
|
-$996K |
| 3 |
Great Point Partners
Greenwich,
Connecticut
|
-$420K |
| 4 |
Sphera Funds Management
Tel Aviv,
Israel
|
-$299K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$279K |
ALIM Hedge Fund Activity: Q4 2016 in Review
47 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q4 2016, worth a combined $33.6M — down 40% from $56.2M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ALIM and 6 opened new positions — a net loss of 5 holders — while 14 trimmed existing stakes and 11 added.
The largest buyer was Stonepine Capital Management, adding an estimated $3.31M. The largest seller was North Run Capital, cutting an estimated $2.16M.
- 47 institutional investors held Alimera Sciences (ALIM) as of Q4 2016, down from 54 in Q3 2016.
- Funds reported $33.6M of Alimera Sciences stock for Q4 2016, down 40% quarter-over-quarter.
- 6 funds opened new Alimera Sciences positions in Q4 2016 and 11 closed out, a net change of -5 holders.
- The largest Alimera Sciences buyer in Q4 2016 was Stonepine Capital Management, an estimated $3.31M added.
- The largest Alimera Sciences seller in Q4 2016 was North Run Capital, an estimated $2.16M sold.
Based on aggregated 13F filings for Q4 2016.